| The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites H Gao, G Chakraborty, AP Lee-Lim, Q Mo, M Decker, A Vonica, R Shen, ... Cell 150 (4), 764-779, 2012 | 440 | 2012 |
| Osteopontin promotes vascular endothelial growth factor–dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms G Chakraborty, S Jain, GC Kundu Cancer research 68 (1), 152-161, 2008 | 308 | 2008 |
| Multi-organ site metastatic reactivation mediated by non-canonical discoidin domain receptor 1 signaling H Gao, G Chakraborty, Z Zhang, I Akalay, M Gadiya, Y Gao, S Sinha, J Hu, ... Cell 166 (1), 47-62, 2016 | 219 | 2016 |
| Prostaglandin E2 regulates tumor angiogenesis in prostate cancer S Jain, G Chakraborty, R Raja, S Kale, GC Kundu Cancer research 68 (19), 7750-7759, 2008 | 213 | 2008 |
| The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis G Chakraborty, S Jain, R Behera, M Ahmed, P Sharma, V Kumar, ... Current molecular medicine 6 (8), 819-830, 2006 | 163 | 2006 |
| The polycomb repressor complex 1 drives double-negative prostate cancer metastasis by coordinating stemness and immune suppression W Su, HH Han, Y Wang, B Zhang, B Zhou, Y Cheng, A Rumandla, ... Cancer cell 36 (2), 139-155. e10, 2019 | 160 | 2019 |
| Osteopontin as a therapeutic target for cancer M Bandopadhyay, A Bulbule, R Butti, G Chakraborty, P Ghorpade, ... Expert opinion on therapeutic targets 18 (8), 883-895, 2014 | 144 | 2014 |
| A novel mechanism driving poor-prognosis prostate cancer: overexpression of the DNA repair gene, ribonucleotide reductase small subunit M2 (RRM2) YZ Mazzu, J Armenia, G Chakraborty, Y Yoshikawa, SAA Coggins, ... Clinical Cancer Research 25 (14), 4480-4492, 2019 | 120 | 2019 |
| The crucial role of cyclooxygenase-2 in osteopontin-induced protein kinase C α/c-Src/IκB kinase α/β–dependent prostate tumor progression and angiogenesis S Jain, G Chakraborty, GC Kundu Cancer Research 66 (13), 6638-6648, 2006 | 100 | 2006 |
| Semaphorin 3A suppresses tumor growth and metastasis in mice melanoma model G Chakraborty, S Kumar, R Mishra, TV Patil, GC Kundu PloS one 7 (3), e33633, 2012 | 96 | 2012 |
| Significance of BRCA2 and RB1 Co-loss in Aggressive Prostate Cancer Progression G Chakraborty, J Armenia, YZ Mazzu, S Nandakumar, KH Stopsack, ... Clinical Cancer Research 26 (8), 2047-2064, 2020 | 94 | 2020 |
| Osteopontin: a potentially important therapeutic target in cancer M Ahmed, R Behera, G Chakraborty, S Jain, V Kumar, P Sharma, ... Expert opinion on therapeutic targets 15 (9), 1113-1126, 2011 | 86 | 2011 |
| Hypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis G Chakraborty, H Rangaswami, S Jain, GC Kundu Journal of biological chemistry 281 (16), 11322-11331, 2006 | 83 | 2006 |
| Osteopontin: an emerging therapeutic target for anticancer therapy S Jain, G Chakraborty, A Bulbule, R Kaur, GC Kundu Expert Opinion on Therapeutic Targets 11 (1), 81-90, 2007 | 80 | 2007 |
| Curcumin suppresses breast tumor angiogenesis by abrogating osteopontin-induced VEGF expression G Chakraborty, S Jain, S Kale, R Raja, S Kumar, R Mishra, GC Kundu Molecular Medicine Reports 1 (5), 641-646, 2008 | 69 | 2008 |
| Forward genetic screens in mice uncover mediators and suppressors of metastatic reactivation H Gao, G Chakraborty, AP Lee-Lim, KJ Mavrakis, HG Wendel, ... Proceedings of the National Academy of Sciences 111 (46), 16532-16537, 2014 | 66 | 2014 |
| Down‐regulation of osteopontin attenuates breast tumour progression in vivo G Chakraborty, S Jain, TV Patil, GC Kundu Journal of cellular and molecular medicine 12 (6a), 2305-2318, 2008 | 64 | 2008 |
| Semaphorin 3A upregulates FOXO 3a-dependent MelCAM expression leading to attenuation of breast tumor growth and angiogenesis R Mishra, D Thorat, G Soundararajan, SJ Pradhan, G Chakraborty, ... Oncogene 34 (12), 1584-1595, 2015 | 62 | 2015 |
| ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D K Komura, Y Yoshikawa, T Shimamura, G Chakraborty, TA Gerke, ... The Journal of clinical investigation 128 (7), 2979-2995, 2018 | 60 | 2018 |
| Functional characterization of stromal osteopontin in melanoma progression and metastasis S Kumar, P Sharma, D Kumar, G Chakraborty, M Gorain, GC Kundu PloS one 8 (7), e69116, 2013 | 55 | 2013 |
